Not applicableUnknownNCT06194565What this trial is testing99mTc-ABH2 SPECT/CT in Breast CancerWho this might be right forBreast Cancer Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT00351858What this trial is testingSafety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast CancerWho this might be right forBreast NeoplasmsBreast Cancer Neovii Biotech 40
Early research (Phase 1)Looking for participantsNCT04686305What this trial is testingPhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLCWho this might be right forLocally Advanced or Metastatic Non-Small Cell Lung Cancer AstraZeneca 304
Not applicableUnknownNCT06238284What this trial is testingHER2 Expression in Gynecological Malignant Tumors in Chongqing Area of ChinaWho this might be right forCervical CancerEndometrial CancerOvarian Cancer+1 more Chongqing University Cancer Hospital 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07047443What this trial is testingSHR-1811 Combined With Carboplatin in the Treatment of Advanced Breast Cancer With HER2 ExpressionWho this might be right forBreast Cancer Anhui Provincial Cancer Hospital 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04872985What this trial is testingPyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast CancerWho this might be right forBreast CancerHormone-receptor Positive Breast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 140
Not applicableLooking for participantsNCT07331506What this trial is testingValidation of the Oncoliq Test for the Early Detection of Breast Cancer.Who this might be right forBreast Cancer DetectionBreast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Cancer Female+5 more Oncoliq US Inc 300
Early research (Phase 1)Study completedNCT04277338What this trial is testingMolecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3Who this might be right forPrimary Breast Cancer Tomsk National Research Medical Center of the Russian Academy of Sciences 30
Early research (Phase 1)Looking for participantsNCT07029399What this trial is testingA Study With NKT5097 for Adults With Advanced/Metastatic Solid TumorsWho this might be right forHR+ Breast CancerTriple Negative Breast Cancer (TNBC)CCNE1 Amplified Advanced Solid Tumors+4 more NiKang Therapeutics, Inc. 205
Testing effectiveness (Phase 2)Study completedNCT02491892What this trial is testingPertuzumab in Participants With Metastatic Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 79
Not applicableStudy completedNCT00898898What this trial is testingStudying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831Who this might be right forBreast Cancer Alliance for Clinical Trials in Oncology 2,837
Testing effectiveness (Phase 2)Looking for participantsNCT06656624What this trial is testingEfficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)Who this might be right forAdvanced Breast Cancer The First Affiliated Hospital with Nanjing Medical University 190
Not applicableUnknownNCT03655353What this trial is testing68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast CancerWho this might be right forHER2-positive Breast Cancer Henrik Lindman 160
Testing effectiveness (Phase 2)Ended earlyNCT01207102What this trial is testingStudy Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Duke University 10
Testing effectiveness (Phase 2)Ended earlyNCT00726180What this trial is testingUse of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast CancerWho this might be right forBreast Cancer University of Michigan Rogel Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT07523529What this trial is testingBiomarker-Guided Dual-Target CAR-T Cells for Advanced Solid TumorsWho this might be right forAdvanced UnresectableMetastatic Beijing Biotech 72
Not applicableLooking for participantsNCT07376174What this trial is testingThe Prognostic Impact of HER2 Expression in Non-Metastatic HER2-Positive Breast Cancer Treated With Dual HER2-Targeted TherapyWho this might be right forBreast CancerHER2/CEP17 Ratio Shandong Cancer Hospital and Institute 300
Not applicableStudy completedNCT05217381What this trial is testingReal-World Data of Clinicopathological Characteristics and Management of Breast Cancer Patients According to HER2 StatusWho this might be right forEarly Breast CancerMetastatic Breast CancerLocally Advanced Breast Cancer MedSIR 18,533
Not applicableNot Yet RecruitingNCT06950671What this trial is testingRole of Triggering Receptor Expressed on Myeloid Cells (TREM-1) as a Novel Biomarker in Human Epidermal Growth Factor Receptor -2 (HER-2) Negative Breast Cancer: a Molecular and Clinical StudyWho this might be right forBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III+1 more Rahma Esam Salama Esawi 1
Not applicableUnknownNCT01424865What this trial is testingCancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 TrialWho this might be right forBreast Cancer NSABP Foundation Inc 1,874